These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19127957)

  • 1. Challenges in pediatric drug development: a pharmaceutical industry perspective.
    Rose K
    Paediatr Drugs; 2009; 11(1):57-9. PubMed ID: 19127957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of pediatric aspects into the general drug development process.
    Rose K
    Ernst Schering Res Found Workshop; 2007; (59):123-34. PubMed ID: 17117719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.
    Chin WW; Joos A
    Eur J Pediatr; 2016 Dec; 175(12):1881-1891. PubMed ID: 27646479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases.
    Sosnik A; Seremeta KP; Imperiale JC; Chiappetta DA
    Expert Opin Drug Deliv; 2012 Mar; 9(3):303-23. PubMed ID: 22257003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric formulations: international issues and potential solutions.
    Knoppert DC
    Paediatr Drugs; 2009; 11(1):55-6. PubMed ID: 19127956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European perspectives on pediatric formulations.
    Breitkreutz J
    Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug discovery: a historical perspective.
    Drews J
    Science; 2000 Mar; 287(5460):1960-4. PubMed ID: 10720314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
    Giacoia GP; Taylor-Zapata P; Zajicek A
    Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug development for children: how is pharma tackling an unmet need?
    Hawcutt DB; Smyth RL
    IDrugs; 2008 Jul; 11(7):502-7. PubMed ID: 18600597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatric Formulation Initiative: selected reports from working groups.
    Giacoia GP; Taylor-Zapata P; Mattison D
    Clin Ther; 2008 Nov; 30(11):2097-101. PubMed ID: 19108797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology and optimal therapeutics in developing countries: aspirations and hopes of the Pediatric Clinical Pharmacology Subcommittee.
    MacLeod SM
    J Clin Epidemiol; 1991; 44 Suppl 2():89S-93S. PubMed ID: 2045848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.
    Lopez FL; Ernest TB; Tuleu C; Gul MO
    Expert Opin Drug Deliv; 2015; 12(11):1727-40. PubMed ID: 26165848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pediatric studies initiative: after 15 years have we reached the limits of the law?
    Milne CP; Davis J
    Clin Ther; 2014 Feb; 36(2):156-62. PubMed ID: 24529287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing paediatric medicines: identifying the needs and recognizing the challenges.
    Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
    J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing and delivering clinical pharmacology in pharmaceutical companies.
    Richards D
    Br J Clin Pharmacol; 2012 Jun; 73(6):870-3. PubMed ID: 22360674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Bonne Année", "Gutes Neues Jahr"? Will 2007 be a "Happy New Year" for children's medicines in Europe?
    Stephenson T
    Arch Dis Child; 2007 Aug; 92(8):661-3. PubMed ID: 17642477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.